<DOC>
	<DOC>NCT02111434</DOC>
	<brief_summary>The study is designed to answer the following questions: 1. What is the levels of visceral adiposity index and Triglycerides/HDL cholesterol ratio in hypogonadism? 2. What is the effect of testosterone replacement on the visceral adiposity index and Triglycerides/HDL cholesterol ratio?</brief_summary>
	<brief_title>Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment</brief_title>
	<detailed_description>This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2007-2010.</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men Congenital hypogonadism Treatment Naive Previous history of androgen replacement Hypertension Diabetes mellitus</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>visceral adiposity index</keyword>
	<keyword>triglycerides / hdl cholesterol ratio</keyword>
	<keyword>testosterone</keyword>
</DOC>